Drugs / patent blue V dye
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase not applicable2 trials | ||||||
| — | NCT00052676 | Oct 2002 → May 2007 | breast cancer | Centre Paul Strauss | Completed | No outcome recorded |
| — | NCT00003654 | Sep 1997 → Jan 2000 | breast cancer | UNICANCER | Terminated | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT00005821 Background | Dec 1998 → ? | female breast carcinoma | Royal Marsden NHS Foundation Trust | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | patent blue V dye | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00052676 ↗ |
| Modality | Diagnostic / imaging agent | “Patients are injected with patent blue V dye near the tumor and a gamma detection probe is used to measure radioactive counts in the sentinel node.” NCT00005821 ↗ |
| Route | Other | “Patients receive patent blue V dye injection peritumorally prior to surgery.” NCT00003654 ↗ |